By focusing on the strategic implications of global pharma news, Scrip supports timely and tactical decision making throughout the entire drug discovery, development, and product life cycle value chain. From biotech start-ups to multinational pharma giants, Scrip provides critical intelligence on the latest licensing opportunities, partnership deals, R&D activity, company developments and market access insights.

Scrip, now part of Citeline (a Norstella company), is a premier provider of news, analysis, and data for the global biopharmaceutical industry, offering crucial commercial intelligence on licensing, deals, R&D, market access, and company developments, helping professionals make strategic decisions from drug discovery to market launch.

Background and Format: SCRIP Intelligence seeks to provide vital original pharmaceutical industry ideas and global signals for career, business and future planning. Customers receive a glimpse of the future from the daily drumbeat of crucial events across the sector spectrum – from biotech start-ups to multinational giants; research boutiques to generic manufacturers; and suppliers large and small. Experienced writers and analysts are based in key geographic markets to convey all aspects of the industry. Global hot topics such as orphan diseases, personalized medicine, and management strategies from developed to emerging markets are covered with local depth and insight. Audience and Readership: SCRIP has over 17,000 registered users consisting of mid-to-C-Level managers and executives working across all disciplines in pharmaceutical and biotech companies, worldwide (source Publisher). 100% of the world top 100 pharma companies subscribe to SCRIP. Their global reach includes subscribers in 85 countries.

Background and Format: SCRIP Intelligence seeks to provide vital original pharmaceutical industry ideas and global signals for career, business and future planning. Customers receive a glimpse of the future from the daily drumbeat of crucial events across the sector spectrum – from biotech start-ups to multinational giants; research boutiques to generic manufacturers; and suppliers large and small. Experienced writers and analysts are based in key geographic markets to convey all aspects of the industry. Global hot topics such as orphan diseases, personalized medicine, and management strategies from developed to emerging markets are covered with local depth and insight. In addition to their internal resources, SCRIP Intelligence reaches out to expert colleagues in other Informa businesses including Datamonitor, Citeline, Scrip Business Insights, Scrip Regulatory Affairs, Clinica and the Informa Healthcare journals. Audience and Readership: SCRIP has over 17,000 registered users consisting of mid-to-C-Level managers and executives working across all disciplines in pharmaceutical and biotech companies, worldwide (source Publisher). 100% of the world top 100 pharma companies subscribe to SCRIP. Their global reach includes subscribers in 85 countries. Circulation / MUU: SCRIP attracts 55,000 unique web visitors every month (source Publisher). Distribution: SCRIP Intelligence is available in a variety of formats, including online, mobile, email, podcasts and video. This includes daily and a weekly email alerts. Ad rates: For further information visit http://advertising.scripintelligence.com/

Background and Format: SCRIP Intelligence seeks to provide vital original pharmaceutical industry ideas and global signals for career, business and future planning. Customers receive a glimpse of the future from the daily drumbeat of crucial events across the sector spectrum – from biotech start-ups to multinational giants; research boutiques to generic manufacturers; and suppliers large and small. Experienced writers and analysts are based in key geographic markets to convey all aspects of the industry. Global hot topics such as orphan diseases, personalized medicine, and management strategies from developed to emerging markets are covered with local depth and insight. In addition to their internal resources, SCRIP Intelligence reaches out to expert colleagues in other Informa businesses including Datamonitor, Citeline, Scrip Business Insights, Scrip Regulatory Affairs, Clinica and the Informa Healthcare journals.   Audience and Readership: SCRIP has over 17,000 registered users consisting of mid-to-C-Level managers and executives working across all disciplines in pharmaceutical and biotech companies, worldwide (Source Publisher). 100% of the world top 100 pharma companies subscribe to SCRIP. Their global reach includes subscribers in 85 countries. Distribution: SCRIP Intelligence is available in a variety of formats, including online, mobile, email, podcasts and video. This includes daily and a weekly email alerts.

Scripps News, formerly Newsy, delivers compelling, context-driven news, fact-based reporting, and a deeper look at the at the "why" of each story with objective, impactful storytelling.

Scripps News, formerly Newsy, delivers compelling, context-driven news, fact-based reporting, and a deeper look at the at the "why" of each story with objective, impactful storytelling.

Naples Daily News is a local newspaper published for the residents of Naples and Collier County, FL. The newspaper covers local and national news, business, arts & entertainment, events and sports.

ScrippsNews covers News

Online-only as of December 2011. Dedicated to professional screenwriters interested in the movie-of-the-week market, from industrial scripts to shorts to features. Includes working writers sharing their experiences and top development executives describing what they look for in a script. Provides coverage of contests, festivals, Web sites, resources, sales and upcoming releases for the screenwriting industry. All press releases and article queries should be sent to the main submissions outlet email.